Onconetix, Inc. (ONCO)
Onconetix, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Onconetix, Inc. (ONCO) is a Biotechnology company based in US with a market capitalization of $400.8K. Revenue declined 67.7% year-over-year and free cash flow was negative at -$9.7M. This page tracks ONCO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 12 employees · IPO Feb 18, 2022
Valuation
Valuation & price
$0.82as of Jul 26, 2026· -99.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.03
P/B ratio
Market cap ÷ book equity
No dividend
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$400.8K
Market cap
-67.7%
Revenue growth (YoY)
77.6%
Gross margin
-$9.7M
Free cash flow (USD)
-$5.2M
Net debt
Net cash position
2803.1%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2023 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventMay 19, 2026Filing
Reverse Stock Split
- 8-K eventMay 14, 2026Filing
Q1 2026 Progress Report
- Quarterly reportMay 13, 2026Filing
10-Q Filed
- 8-K eventMay 4, 2026Filing
Stockholder Meeting Results
- 8-K eventApr 24, 2026Filing
Board Resignation and Appointment
- Insider sellApr 22, 2026Filing
Insider Sell $34KHRT FINANCIAL LP · 10% Owner · $34.3K
- Insider sellApr 21, 2026Filing
Insider Sell $110KHRT FINANCIAL LP · 10% Owner · $110.2K
- Insider buyApr 16, 2026Filing
Insider Buy $128KHRT FINANCIAL LP · 10% Owner · $127.6K
Questions
Frequently asked questions
What is Onconetix, Inc.'s market cap?
Onconetix, Inc. (ONCO) has a market capitalization of $400.8K.
What is ONCO's P/E ratio?
A meaningful P/E ratio is not available for ONCO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ONCO's price-to-book (P/B) ratio?
ONCO trades at 0.03 times book value per share.
Does Onconetix, Inc. pay a dividend?
No — ONCO did not pay a dividend in its latest reported fiscal year.
Are insiders buying ONCO stock?
SEC Form 4 filings show no open-market insider buys at Onconetix, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.